Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

SOLACI PERIPHERAL | 3rd Clinical Case: Femoral PCI

angioplastia femoral

In keeping with its Clinical Case Discussion Program, SOLACI’s peripheral interventions department, SOLACI Peripheral, presents the third clinical case, to promote knowledge exchange across the entire Latin American hemodynamics community. 

Share your thoughts on case and resolution in the comments and answer the questions at the end of the article.


Femoral PCI


Authors: MD Mauricio Cavalieri Machado / MD Caiser T. S. Junior / MD Thiago José de Assis

Contact: mcavmachado@gmail.com

Healthcare centerLuxemburgo Hospital, Belo Horizonte/ MG. Brazil.


– Patient: 75-year-old woman. Stenting of right and left femoral arteries in 2018.

– Patient informs intermittent claudication after 100 m walk is back, with pain in lower right and left limbs (Fontaine IIB, Rutherford 4).

– History of hypertension, hypothyroidism, dyslipidemia, and atrial fibrillation. Use of losartan 50 mg BID, amlodipine 10 mg MID, simvastatin 40 mg MID, Hidantal, rivaroxaban 20 mg MID, amiodarone, Puran t4 75 mcg/day, fluoxetine 20 mg/day.

– Lower limb echo-doppler shows new occlusions in both femoral arteries. Distal bed is good.

These are the angiography images. TASC D occlusions.

Left lower limb

Right lower limb

Question… What course of action should we recommend?

Case Solution

– We treated both lower limbs percutaneously. We stopped using rivaroxaban and started ASA and clopidogrel 48hrs before procedure.

– To treat the left SFA, we performed a contralateral retrograde right CFA puncture and placed a 6F sheath, 45 cm long. We attempted crossing proximal occlusion into stent lumen, but the guidewire would go to false lumen.

– We then opted for distal SFA approach, with a 4F inductor and retrograde puncture through the thigh.

– We crossed the occlusion and exteriorized the guidewire

– We performed balloon dilation and successfully completed with drug coated balloon.

– One month after first intervention, we treated the right SFA.

– We now puncture the left CFA using contralateral femoral sheath placement. We successfully penetrated proximal stent occlusion but when exiting, there was vessel dissection and the guidewire stayed in false lumen, which prevented advancing along the popliteal.

12- Guidewire in popliteal false lumen

– Once more we opted for the retrograde approach in leg. This time punctured the anterior tibial artery (images 13, 14), advanced the 0,014 guidewire in a retrograde fashion, and exteriorized it (video 2).

– Guidewire snaring.

– Balloon dilation successfully completed with drug coated balloon (images 15,16).

Devices used:

  • 6F Sheath
  • 4F Sheath
  • 0,035 260 cm stiff hydrophilic guidewires
  • IM catheter
  • Long sheath 50 cm Destination
  • Oceanus 35 4 X 80 and 5 X 150 balloon
  • 3,5 X 60 OTW balloon
  • Admiral 6 X 150 cm paclitaxel coated balloon
  • 0,014 PT2 300 cm guidewire
  • 5F Glidecath catheter

Question: what measurements would you use to prevent repeat stent thrombosis?


Conclusions

  • Endovascular treatment can be used in TASC A to D lesions
  • The most popular bailout technique for challenging rechannelization is the retrograde approach which, in addition to good outcomes, has excellent cost-benefit ratio.
  • Drug coated balloons can be used for stent restenosis.

Discover other SOLACI Peripheral clinical cases

 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SOLACI Presented an Outstanding Scientific Session on Complex Coronary Lesions at EuroPCR 2026

The Latin American Society of Interventional Cardiology (SOLACI) had a prominent participation at EuroPCR 2026 through an institutional scientific session held on May 21...

Relive SOLACI’s participation in the V International Congress of Clinical and Interventional Cardiology in the Dominican Republic

The Latin American Society of Interventional Cardiology actively participated in the “V International Congress of Clinical and Interventional Cardiology”, organized by the Asociación Dominicana...

SOLACI to Participate in EuroPCR 2026 with a Scientific Session Focused on the Management of Complex Coronary Lesions

The Latin American Society of Interventional Cardiology will have a prominent participation at EuroPCR 2026 through an institutional scientific session bringing together renowned international...

The Preliminary Scientific Program for SOLACI & SBHCI 2026 Is Now Available

The SOLACI & SBHCI 2026 Congress is already beginning to take shape with the official release of its Preliminary Scientific Program — a high-impact...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...